Irene M. Hramiak

St Joseph's Health Care London
London, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial.

Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial.

Journal: Obesity (Silver Spring, Md.)

Published: August 13, 2024

Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.

Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.

Journal: Diabetes care

Published: March 07, 2024

Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.

Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.

Journal: Diabetes, obesity & metabolism

Published: April 13, 2023

Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers.

Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: August 11, 2022

Effectiveness of Nonmydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease: A Randomized Controlled Trial (Clearsight).

Effectiveness of Nonmydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease: A Randomized Controlled Trial (Clearsight).

Journal: Diabetes care

Published: April 12, 2022

Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin to iGlarLixi in the LixiLan ONE CAN randomized trial.

Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin to iGlarLixi in the LixiLan ONE CAN randomized trial.

Journal: Diabetes, obesity & metabolism

Published: February 15, 2022

Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial.

Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial.

Journal: Diabetes care

Published: February 02, 2021

Low prevalence of fibrate use in adults with type 1 and type 2 diabetes and established diabetic retinopathy.

Low prevalence of fibrate use in adults with type 1 and type 2 diabetes and established diabetic retinopathy.

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

Published: December 30, 2020

Metformin and carotid intima-media thickness in never-smokers with type 1 diabetes: The REMOVAL trial.

Metformin and carotid intima-media thickness in never-smokers with type 1 diabetes: The REMOVAL trial.

Journal: Diabetes, obesity & metabolism

Published: October 27, 2020

Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.

Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.

Journal: The American journal of gastroenterology

Published: July 04, 2020

Switching between GLP-1 receptor agonists in clinical practice: Expert consensus and practical guidance.

Switching between GLP-1 receptor agonists in clinical practice: Expert consensus and practical guidance.

Journal: International journal of clinical practice

Published: June 24, 2020

Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin.

Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 22, 2019

Showing 1-12 of 43

Last Updated: 09/26/2026